Washington University’s Maze Therapeutics MAZE Stock Holding History

Washington University’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-280,802	Closed	-$8.38M	–	4
2026 Q1	$8.38M	Hold	280,802	–	–	5.23%	2
2025 Q4	$11.6M	Buy	280,802 +70,121	+33%	+$2.41M	5.88%	2
2025 Q3	$5.46M	Buy	+210,681	New	+$3.56M	3.06%	2

Other funds holding MAZE

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FWP

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Washington University's MAZE Position: Q2 2026 in Review

Washington University sold out of Maze Therapeutics (MAZE) in Q2 2026, closing a stake of 280,802 shares — an estimated $8.38M sold.

Washington University first reported a position in MAZE in Q3 2025 and held it in 3 quarters. The position peaked at $11.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

Washington University reported no remaining Maze Therapeutics position as of Q2 2026 after selling out during the quarter.
Washington University sold 280,802 Maze Therapeutics shares in Q2 2026, an estimated $8.38M.
Washington University first reported a position in Maze Therapeutics in Q3 2025 and held it in 3 quarters.
Washington University's Maze Therapeutics position peaked at $11.6M in Q4 2025.
7 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Washington University's 13F filing for Q2 2026, filed 14 Jul 2026.